The number of pregnant women with opioid use disorder at labor and delivery more than quadrupled between 1999 and 2014, to 6.5 per 1,000 hospital births, according to a new analysis by the Centers for Disease Control and Prevention. State rates in 2014 varied widely, from 0.7 per 1,000 in Washington, D.C. to 48.6 per 1,000 in Vermont. The variance may reflect differences in opioid prescribing rates and illicit drug use as well as improved screening, diagnosis and treatment for OUD and neonatal abstinence syndrome, the report notes. “Even in states with the smallest annual increases, more and more women are presenting with opioid use disorder at labor and delivery,” said Wanda Barfield, M.D., director off CDC’s Division of Reproductive Health. “These state-level data can provide a solid foundation for developing and tailoring prevention and treatment efforts.” OUD during pregnancy has been associated with negative health outcomes for mothers and their babies, including maternal death, preterm birth, stillbirth and neonatal abstinence syndrome.

Headline
Katie Au, M.D., and Katherine Jorda, M.D., directors of the Perinatal Trauma Clinic at Oregon Health & Science University, explore how…
Headline
The U.S. birth rate declined by 1% in 2025, according to preliminary data released by the Centers for Disease Control and Prevention. The cesarean delivery…
Blog
h2, h3, h4 {color: #002855;} Postpartum hemorrhage (PPH) is one of the most common — and preventable — causes of maternal health in the United States. The…
Headline
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…
Headline
The U.S. maternal mortality rate fell to 17.9 deaths per 100,000 live births in 2024, statistically similar to the 2023 rate of 18.6 per 100,000,…
Headline
The AHA and Epic are launching the Safer Births PPH Collaborative, a seven-month initiative designed to support hospitals in reducing postpartum hemorrhage…